NCT03226574 2020-10-20
Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
Sorrento Therapeutics, Inc.
Phase 1 Completed
Clinical Trials
4 trialsNCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
NCT00804076 2014-02-19
Gene Transfer for Cancer Pain
Diamyd Inc
Phase 1 Completed
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed